Basic research indicates that the AR pathway interacts with DNA repair genes, with this pathway regulating the expression of several such genes; endocrine therapy can induce a "BRCAness" phenotype in cancer cells, thereby increasing their sensitivity to PARPI [34,70]. Here, AR is linked to cancer.